Peregrine Pharma (PPHM), AstraZeneca (AZN) Expand Cancer Immunotherapy Collaboration
Tweet Send to a Friend
Peregrine Pharma (NASDAQ: PPHM) announced that it has expanded its ongoing cancer immunotherapy clinical collaboration with AstraZeneca (NYSE: AZN) to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE